-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q2 2024.
- Calidi Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $751K, a 30.5% decline year-over-year.
- Calidi Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.93M.
- Calidi Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.81M, a 6.35% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)